TheProfitWatch

PROK - ProKidney Corp. Class A Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.1 0.11 (3.55%) --- 0.0 (0.0%) 0.05 (1.58%) 0.05 (1.61%) 0.02 (0.79%) 0.08 (2.55%) 0.08 (2.55%)

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
99.8
VWAP:
3.21
RVol:
0.5772

Events

Period Kind Movement Occurred At
1m Price increase 1m 3.24 +0.03 (+1.06%) Oct 15 10:31
1m Price increase 1m 3.24 +0.04 (+1.28%) Oct 15 09:34

Related News